Akira Sakurada

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz et al. · New England Journal of Medicine · 2005 · 1.9K citations

Medicine, Oncology, Pharmacology +14

Role of <i>KRAS</i> and <i>EGFR</i> As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding et al. · Journal of Clinical Oncology · 2008 · 665 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Prognostic and Predictive Importance of p53 and RAS for Adjuvant Chemotherapy in Non–Small-Cell Lung Cancer

Ming‐Sound Tsao, Sarit Aviel‐Ronen, Keyue Ding et al. · Journal of Clinical Oncology · 2007 · 325 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Tumor doubling time and prognostic assessment of patients with primary lung cancer

Katsuo Usuda, Yasuki Saito, Motoyasu Sagawa et al. · Cancer · 1994 · 234 citations · Full text

Medicine, Biostatistics, Oncology +16

Accumulation of p62/<scp>SQSTM</scp>1 is associated with poor prognosis in patients with lung adenocarcinoma

Daisuke Inoue, Takashi Suzuki, Yoichiro Mitsuishi et al. · Cancer Science · 2012 · 205 citations · Full text

Medicine, Oncology, Pathology +17